Celebrating the Life, Work & Legacy of Dr. Nancy Cappello
JACR Study (Cappello, Richetelli & Lee) Women in States with Density Reporting Laws are more aware of breast density impact, prompting conversations betwen patient and provider
On March 28, 2019, the Department of Health and Human Services, the FDA announced changes to the MQSA (Mammography Quality Standards Act) to include reporting of dense breast tissue to the patient...
In “read" from the FDA “Breast Density”
"The Committee recognizes the importance of patients receiving their own personal medical information and directs the FDA to ensure that Mammography reports and summaries received by patients and their providers include appropriate information about breast density specified by the Secretary, including, at a minimum, the effect of breast density in masking the presence of breast cancer on a mammogram, the qualitative assessment of the provider who interpreted the mammogram, and a reminder to patients that individuals with dense breast tissue should talk with their providers if they have any questions or concerns about their summary”.